相似文献
1
The FoxO family in cardiac function and dysfunction.
Annu Rev Physiol. 2010;72:81-94. doi: 10.1146/annurev-physiol-021909-135931.
2
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
Circulation. 2006 Sep 12;114(11):1159-68. doi: 10.1161/CIRCULATIONAHA.106.637124. Epub 2006 Sep 4.
3
Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Circ Res. 2008 Mar 28;102(6):686-94. doi: 10.1161/CIRCRESAHA.107.163428. Epub 2008 Jan 24.
4
Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
J Clin Invest. 2007 Nov;117(11):3211-23. doi: 10.1172/JCI31757.
5
Role of FoxO transcription factors in aging-associated cardiovascular diseases.
Vitam Horm. 2021;115:449-475. doi: 10.1016/bs.vh.2020.12.018. Epub 2021 Feb 13.
6
FoxO integration of insulin signaling with glucose and lipid metabolism.
J Endocrinol. 2017 May;233(2):R67-R79. doi: 10.1530/JOE-17-0002. Epub 2017 Feb 17.
7
The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer.
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):360-8. doi: 10.1016/j.taap.2006.12.003. Epub 2006 Dec 15.
8
Role of Forkhead Box O (FOXO) transcription factor in aging and diseases.
Gene. 2018 Mar 30;648:97-105. doi: 10.1016/j.gene.2018.01.051. Epub 2018 Feb 4.
9
FOXOs in the impaired heart: New therapeutic targets for cardiac diseases.
Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):486-498. doi: 10.1016/j.bbadis.2016.11.023. Epub 2016 Nov 24.
10
The "O" class: crafting clinical care with FoxO transcription factors.
Adv Exp Med Biol. 2009;665:242-60. doi: 10.1007/978-1-4419-1599-3_18.
引用本文的文献
1
Cardiac shock wave therapy-induced exosome derived from OGD/R-treated H9c2 cells carrying miR-98-5p promote HUVECs angiogenesis.
Sci Rep. 2025 Apr 30;15(1):15213. doi: 10.1038/s41598-025-00104-4.
2
The role of sirtuins in the regulation of reactive oxygen species in myocardial ischemia/reperfusion injury.
Mol Cell Biochem. 2025 Jun;480(6):3501-3520. doi: 10.1007/s11010-024-05204-9. Epub 2025 Feb 7.
3
Network pharmacology and molecular docking to explore mechanisms of clozapine-induced cardiac arrest.
J Psychiatry Neurosci. 2025 Jan 3;50(1):E1-E10. doi: 10.1503/jpn.240065. Print 2025 Jan-Feb.
4
Adipose-derived exosomes ameliorate skeletal muscle atrophy via miR-146a-5p/IGF-1R signaling.
J Nanobiotechnology. 2024 Dec 18;22(1):754. doi: 10.1186/s12951-024-02983-7.
5
TRIM55: An Enemy at the Post-MI Border?: TRIMming May Not Always Be Good.
JACC Basic Transl Sci. 2024 Sep 23;9(9):1123-1125. doi: 10.1016/j.jacbts.2024.06.009. eCollection 2024 Sep.
6
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy.
J Pharm Pharm Sci. 2024 Aug 14;27:13193. doi: 10.3389/jpps.2024.13193. eCollection 2024.
7
In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation.
Cardiovasc Diabetol. 2024 Jul 18;23(1):258. doi: 10.1186/s12933-024-02338-4.
8
and Its Potential Influence on Key Oncogenic Pathways.
Cells. 2024 Jun 26;13(13):1109. doi: 10.3390/cells13131109.
9
Role of natural products in cardiovascular disease.
Mol Cell Biochem. 2025 Feb;480(2):733-745. doi: 10.1007/s11010-024-05048-3. Epub 2024 Jun 16.
10
Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle-Aged and Older Adults.
J Am Heart Assoc. 2024 Jun 18;13(12):e033674. doi: 10.1161/JAHA.123.033674. Epub 2024 Jun 11.
本文引用的文献
1
A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.
J Biol Chem. 2009 Feb 20;284(8):5148-57. doi: 10.1074/jbc.M808890200. Epub 2008 Dec 22.
2
Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway.
Biochem Biophys Res Commun. 2009 Jan 16;378(3):389-93. doi: 10.1016/j.bbrc.2008.11.110. Epub 2008 Dec 4.
3
The anti-aging, metabolism potential of SIRT1.
Curr Opin Investig Drugs. 2008 Oct;9(10):1095-102.
4
BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.
Circ Res. 2008 Oct 10;103(8):804-12. doi: 10.1161/CIRCRESAHA.108.178434. Epub 2008 Sep 11.
5
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.
Structure. 2008 Sep 10;16(9):1407-16. doi: 10.1016/j.str.2008.06.013.
6
Mdm2 induces mono-ubiquitination of FOXO4.
PLoS One. 2008 Jul 30;3(7):e2819. doi: 10.1371/journal.pone.0002819.
7
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
J Biol Chem. 2008 Aug 29;283(35):24194-201. doi: 10.1074/jbc.M802869200. Epub 2008 Jun 18.
8
Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region.
Biochemistry. 2008 Jun 24;47(25):6719-26. doi: 10.1021/bi800309m.
9
Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
J Biol Chem. 2008 Jul 11;283(28):19201-10. doi: 10.1074/jbc.M710366200. Epub 2008 May 16.
10
Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3.
J Biol Chem. 2008 Jul 11;283(28):19739-47. doi: 10.1074/jbc.M710098200. Epub 2008 May 5.
Zotero 插件